Healthy volunteers test malaria Drug's Long-Term safety
Knowledge-focused
Completed
This study looked at the long-term safety of the malaria drug tafenoquine in 600 healthy adults. Participants took either tafenoquine or a placebo daily for three days, then weekly for 51 weeks. The main focus was on eye health, checking for any serious changes. The study did not…
Phase: PHASE2 • Sponsor: 60 Degrees Pharmaceuticals LLC • Aim: Knowledge-focused
Last updated Jun 17, 2026 01:44 UTC